Hormone Therapy: A Comprehensive Guide in Men’s Health

Discover the important benefits of hormone therapy for men’s health for achieving better physical and mental health.

Abstract

In this comprehensive educational post, I guide you through an integrative, evidence-based approach to men’s sexual health, focusing on two of the most common concerns: erectile dysfunction (ED) and testosterone deficiency. I will explain the intricate vascular and neurochemical physiology of an erection, particularly the nitric oxide–cGMP pathway, and how comorbidities like diabetes, hypertension, obesity, and metabolic syndrome impair both erectile capacity and androgen balance. Drawing on modern clinical trials and consensus guidance from leading researchers, I will review a full spectrum of therapies, from first-line options like PDE5 inhibitors to advanced treatments such as intracavernosal injections, penile implants, and low-intensity shockwave therapy (LiSWT). I will also clarify the diagnostic process for hypogonadism, outlining therapeutic options from testosterone replacement therapy (TRT) to lifestyle-driven strategies, while emphasizing rigorous safety monitoring. This post details how our team at Injury Medical Clinic PA in El Paso, Texas, integrates chiropractic care, functional medicine, and internal medicine oversight to deliver holistic, patient-centered care. Together with our Medical Director, Dr. Maria Guadalupe Cardenas, MD, we align diagnostics, physical interventions, and pharmacologic therapy to optimize your long-term health and vitality.

Introduction to Our Multidisciplinary Men’s Health Model in El Paso, Texas

I am Dr. Alex Jimenez, and I practice in a multidisciplinary clinic where we integrate integrative chiropractic care, functional medicine, and injury rehabilitation under the expert oversight of internal medicine. This collaborative model is designed to address the complex, interconnected systems that govern men’s health.

• Medical Direction: Dr. Maria Guadalupe Cardenas, MD, is Board Certified in Internal Medicine and has practiced for over 40 years. As our Medical Director and Collaborative Physician (NPI #1164426749, Texas MD License #J2933), she ensures medical safety, pharmacologic prudence, and adherence to evidence-based protocols across all complex cases. This setup is common in leading integrative and injury-care clinics, where an MD provides essential medical direction alongside a chiropractor and a functional medicine team.
• Chiropractic Integration: My role involves delivering biomechanical assessments, neuromusculoskeletal care, and rehabilitation programming. These interventions are designed to support vascular health, autonomic nervous system balance, and physical conditioning—all of which are key elements in erectile function and endocrine resilience.
• Functional Medicine: We work to identify and address the root causes of sexual dysfunction, including insulin resistance, dyslipidemia, systemic inflammation, sleep apnea, micronutrient insufficiencies, and environmental stressors that impair nitric oxide bioavailability and testosterone balance.
• Personal Injury and Rehabilitation: We recognize that trauma, pain, and immobility often disrupt sleep, autonomic regulation, and endothelial tone. Our team coordinates manual therapy, therapeutic exercise, and graded activity to restore circulation, reduce sympathetic overdrive, and rebuild physical capacity.

You can explore more of my clinical perspectives and ongoing case notes at my professional sites:

• https://chiropracticscientist.com/
• https://www.linkedin.com/in/dralexjimenez/

Erectile Dysfunction Overview: Prevalence, Impact, and Care-Seeking Patterns

Erectile dysfunction (ED) is defined as the consistent or recurrent inability to achieve or maintain an erection sufficient for satisfactory sexual performance. It’s a condition that affects approximately 30 million men in the United States, with prevalence rising sharply with age, cardiometabolic disease, and neurovascular issues (Khera et al., 2023; Burnett et al., 2018). While the market for ED therapies is expanding, many men delay seeking care, often due to stigma, privacy concerns, or misconceptions about the safety and effectiveness of treatments.

Why this matters clinically:

• Quality of life and relationship strain are significant consequences.
• ED is frequently an early warning sign of systemic endothelial dysfunction and can predict future cardiovascular events (Montorsi et al., 2003).
• Addressing ED can serve as a powerful catalyst for broader, positive lifestyle changes.

The Physiology of an Erection: A Symphony of Vascular and Neural Signals

An erection is a complex neurovascular event that requires perfect synchronization between your nervous system and your blood vessels.

• Neural Initiation: Erotic stimuli (whether from thoughts, sights, or touch) activate parasympathetic nerve pathways. These nerves release the crucial signaling molecule nitric oxide (NO) from both nonadrenergic, noncholinergic (NANC) neurons and the endothelial cells lining the blood vessels of the penis (Burnett et al., 2018).
• The NO–cGMP Cascade: NO diffuses into the smooth muscle cells of the penile arteries and the corpus cavernosum (the spongy erectile tissue). There, it stimulates an enzyme called soluble guanylate cyclase, which converts guanosine triphosphate (GTP) into cyclic guanosine monophosphate (cGMP). This is the key step: cGMP acts as a powerful second messenger, triggering a cascade that lowers intracellular calcium levels.
• Smooth-Muscle Relaxation: The reduction in calcium causes the smooth muscle to relax. This relaxation is the “on” switch for an erection. It dilates the penile arteries, allowing a rapid, massive inflow of blood into the corpus cavernosa, causing it to become engorged and rigid.
• Venous Occlusion: As the corpus cavernosum fills with blood, it expands and compresses the smaller veins (subtunical venules) against the tough, fibrous outer sheath of the penis, the tunica albuginea. This process, known as the veno-occlusive mechanism, traps the blood inside the penis, sustaining the erection and creating rigidity. This requires healthy, compliant cavernosal tissue.
• Termination of Erection: The erection subsides when another enzyme, phosphodiesterase type 5 (PDE5), breaks down cGMP. As cGMP levels fall, calcium levels rise, the smooth muscles contract, blood flow out of the penis resumes, and the penis returns to its flaccid state.
• Pharmacologic Amplification: This is where medications like PDE5 inhibitors come in. They work by blocking the PDE5 enzyme, which prevents the breakdown of cGMP. By keeping cGMP levels elevated, these drugs prolong smooth-muscle relaxation and enhance the erectile response to sexual stimulation.

Risk Factors and Causes: The Endothelial Story

Most cases of ED are rooted in problems with the blood vessels. The major risk factors include hypertension, diabetes, obesity, dyslipidemia, tobacco use, a sedentary lifestyle, and chronic alcohol consumption (Hatzimouratidis et al., 2021). ED is a powerful signal that your vascular system may be in trouble.

• Vasculogenic: Atherosclerosis (hardening of the arteries) and microvascular disease are the most common culprits. They damage the endothelial lining and reduce arterial blood flow to the penis.
• Neurogenic: Conditions like spinal cord injury, multiple sclerosis, or peripheral neuropathy (often from diabetes) can impair the nerve signals required to initiate an erection.
• Endocrine/Metabolic: Low testosterone (hypogonadism) can reduce libido (sexual desire), while insulin resistance fuels inflammation and reduces nitric oxide production.
• Psychogenic: Performance anxiety, depression, and stress can create a state of heightened sympathetic nervous system output (“fight or flight”), which constricts penile arteries and counteracts the parasympathetic “rest and digest” signals needed for an erection.
• Substance-Related: Nicotine is a potent vasoconstrictor. Opioids, cocaine, and certain medications (like some SSRIs, thiazide diuretics, and beta-blockers) can also interfere with erectile function.

Clinical Takeaway: We view ED as a “cardiometabolic vital sign.” The appearance of ED often precedes a major cardiovascular event like a heart attack or stroke by several years, making it a critical window for prevention (Khera et al., 2023).

Understanding Low Testosterone (Hypogonadism)

Men often come to my clinic with a constellation of symptoms: fatigue, low libido, reduced morning erections, decreased muscle mass, and mood changes. While these can point to low testosterone, a rigorous diagnostic approach is essential to avoid misdiagnosis and overtreatment.

Hypogonadism is a clinical syndrome that results from the testicles’ failure to produce adequate testosterone, often due to disruptions in the hypothalamic-pituitary-gonadal (HPG) axis. A diagnosis generally requires two separate morning total testosterone measurements below 300 ng/dL, along with corresponding symptoms (Bhasin et al., 2018).

• The HPG Axis: This delicate feedback loop begins in the brain. The hypothalamus releases gonadotropin-releasing hormone (GnRH), which tells the pituitary gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH travels to the testicles and stimulates the Leydig cells to produce testosterone. Testosterone then signals back to the brain to moderate the release of GnRH and LH, keeping the system in balance.
• Age-Related Decline: Total testosterone naturally declines by about 1–2% per year after a man’s early 30s.

Primary and Secondary Causes of Testosterone Deficiency

We differentiate between primary hypogonadism (testicular failure, indicated by high LH/FSH) and secondary hypogonadism (a problem with the hypothalamus or pituitary, indicated by low or normal LH/FSH).

Secondary causes are very common and often reversible:

• Obesity and Metabolic Syndrome: Excess fat tissue, especially around the abdomen, contains high levels of the aromatase enzyme, which converts testosterone into estradiol (a form of estrogen). This increased estrogen suppresses the HPG axis.
• Obstructive Sleep Apnea (OSA): Intermittent hypoxia and sleep fragmentation during the night disrupt the normal pulsatile release of LH, leading to lower morning testosterone levels (Hoyos et al., 2012).
• Chronic Opioid or Glucocorticoid Use.
• Excess Alcohol Intake and Chronic Illness.

Our integrative model focuses on identifying and reversing these upstream drivers before jumping to hormone replacement.

Our Comprehensive Assessment and Diagnostic Algorithm

A thorough evaluation is the cornerstone of effective treatment. We use validated questionnaires and a detailed history to understand the full picture.

Validated Questionnaires:

• International Index of Erectile Function (IIEF): A 15-item gold standard for assessing erectile function (Rosen et al., 1997).
• Sexual Health Inventory for Men (SHIM): A quick 5-item version, practical for routine clinical use.

Diagnostic Lab Workup:

• Morning Total Testosterone: Essential. Testosterone levels follow a diurnal rhythm, peaking between 7–10 a.m. Testing at other times can lead to a false diagnosis. We require at least two separate morning readings to confirm low testosterone.
• Additional Hormone Labs: If testosterone is low, we check LH, FSH, and prolactin to distinguish between primary and secondary hypogonadism.
• Cardiometabolic Panel: Fasting lipids, HbA1c (to assess for diabetes), fasting glucose, and inflammatory markers like hs-CRP.
• Prostate-Specific Antigen (PSA): Per age and risk guidelines, as both low T and TRT can affect the prostate.

We combine this data with a comprehensive sexual and medical history, a focused physical exam, and a psychosocial review to build a complete clinical picture.

A Stepwise Treatment Pathway: From Lifestyle to Advanced Therapies

We emphasize shared decision-making, tailoring therapy to your unique physiology, goals, and preferences.

First-Line Foundation: Lifestyle and Risk Factor Modulation

Lifestyle changes are not just adjuncts; they are foundational. They amplify the effectiveness of any other therapy and reduce your long-term cardiovascular risk.

• Weight Loss and Exercise: Meta-analyses show that moderate-intensity aerobic exercise significantly improves erectile function (Silva et al., 2017). Resistance training helps build muscle and improve insulin sensitivity.
• Nutrition: We emphasize a Mediterranean-style dietary pattern. This includes nitrate-rich vegetables like arugula, spinach, and beets, which your body can convert into nitric oxide. Polyphenol-rich foods like berries and dark cocoa provide antioxidants that protect endothelial cells.
• Sleep Optimization: Treating obstructive sleep apnea with CPAP can significantly raise testosterone levels and improve endothelial health.
• Smoking Cessation and Alcohol Moderation.

PDE5 Inhibitors: Evidence-Based Pharmacotherapy

Agents such as sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra), and avanafil (Stendra) are the most common first-line medical treatments for ED (Hatzimouratidis et al., 2021).

• Mechanism: As discussed, they inhibit PDE5, preventing the breakdown of cGMP and thereby sustaining smooth muscle relaxation. They don’t create an erection but enhance the body’s natural response to stimulation.
• Practical Use:

• • Timing: Most are taken on-demand, 30–60 minutes before sexual activity. Tadalafil is unique in that it can be taken as a low daily dose (e.g., 5 mg), providing more spontaneity.
  • Food Effects: A high-fat meal can delay sildenafil absorption, so I counsel patients to take it on an empty stomach for optimal results.
  • Safety: The most critical contraindication is the concurrent use of nitrates (like nitroglycerin for chest pain), which can cause a life-threatening drop in blood pressure.
  • Side Effects: The most common are headache, flushing, nasal congestion, and dyspepsia.

In our clinic, a common strategy is to use daily low-dose tadalafil (5 mg) to improve endothelial function over time, combined with an on-demand “pulse” dose of up to 20 mg when needed. This is always done with careful blood pressure monitoring and medical oversight from Dr. Cardenas.

Advanced and Second-Line Therapies for ED

When oral medications are ineffective or poorly tolerated, we have several other powerful options.

• Vacuum Erection Devices (VED): A VED uses a plastic cylinder and a pump to create negative pressure, which draws blood into the penis. A constriction ring is then placed at the base to maintain the erection. It’s a safe and effective mechanical solution, especially for men with significant vascular disease.
• Intracavernosal Injections (ICI): This involves injecting medication directly into the corpus cavernosum.

• • Options: FDA-approved alprostadil or compounded mixtures like Bimix and Trimix.
  • Mechanism: These agents are powerful vasodilators that cause direct smooth-muscle relaxation, bypassing the need for nerve signals. They are highly effective, even in men with severe diabetes or post-prostatectomy ED.
  • Initiation: We always start with a low-dose in-office test to determine the right dose and teach proper injection technique. The main risk is priapism (a prolonged, painful erection), so careful patient education is critical.

• Penile Prosthesis (Implant): For men with severe ED who have not had success with other treatments, a penile prosthesis offers a permanent and reliable solution. Modern inflatable devices have patient satisfaction rates exceeding 90% (Carson & Kirshenbaum, 2011). It’s a surgical procedure that provides predictable, on-demand rigidity.
• Low-Intensity Shockwave Therapy (LiSWT): This emerging therapy uses focused sound waves to stimulate neovascularization (the growth of new blood vessels) and improve endothelial function in the penile tissue (Lu et al., 2017). It’s a restorative approach aimed at improving natural function. In my practice, we have seen functional improvements in select patients with mild-to-moderate vasculogenic ED, especially when paired with aggressive lifestyle changes.

Signs of Hormonal Imbalances In Men *THIS IS WHY*- Video

Testosterone Replacement Therapy (TRT): A Guided Approach

If a man has confirmed low testosterone with significant symptoms, and reversible causes have been addressed, we may consider TRT. The goal is to restore testosterone to a physiologic, mid-normal range (often 450–650 ng/dL) to alleviate symptoms.

Common Formulations:

• Intramuscular Injections: Testosterone cypionate or enanthate are cost-effective and widely used. Dosing can be weekly or bi-weekly, with some patients preferring more frequent micro-dosing to minimize hormonal peaks and troughs.
• Transdermal Gels: These provide stable daily levels but require careful application to prevent accidental transfer to partners or children.
• Subdermal Pellets: Implanted under the skin every 3–4 months, offering convenience and steady-state levels.
• Oral Testosterone Undecanoate: A newer option that bypasses the liver, but may carry warnings about blood pressure elevation.

Non-Negotiable Safety Monitoring: Under Dr. Cardenas’s medical direction, we follow a strict monitoring protocol.

• Hematocrit: TRT can stimulate red blood cell production. We monitor for erythrocytosis (hematocrit >54%), which can increase blood viscosity and the risk of clotting.
• PSA: We monitor PSA levels in accordance with standard urological guidelines.
• Cardiometabolic Markers: We track blood pressure, lipids, and blood sugar.
• Fertility: TRT suppresses natural sperm production. For men desiring future fertility, we consider alternative strategies like clomiphene citrate, an oral medication that stimulates the body’s own testosterone production.

The Role of Integrative Chiropractic Care in Men’s Sexual and Hormonal Health

As a chiropractor and advanced practice nurse, I focus on the crucial link between the neuromusculoskeletal system, autonomic function, and sexual health. Chronic pain and physical dysfunction can significantly elevate sympathetic tone (“fight or flight”) and systemic inflammation, both of which are detrimental to erectile function and hormonal balance.

My evidence-informed chiropractic and rehabilitative strategies aim to:

• Improve Pelvic and Spinal Mechanics: Restrictions in the pelvic girdle or lumbar spine can compromise nerve function and blood flow to the pelvic organs. Manual adjustments and soft tissue therapy can optimize neurovascular dynamics (Capogrosso et al., 2015).
• Modulate the Autonomic Nervous System: Chronic pain is a major stressor that keeps the sympathetic nervous system on high alert. By reducing nociceptive input through precise adjustments and corrective exercise, we can help shift the body toward a more parasympathetic (“rest and digest”) state, which is essential for erections and restorative sleep.
• Enhance Breathing Mechanics: I often work on thoracic cage and diaphragm mobility, especially in men with OSA. Better breathing mechanics can improve CPAP tolerance and sleep quality, which directly impacts testosterone production.
• Enable Consistent Exercise: By correcting movement patterns and reducing pain, we enable patients to engage in the resistance training and aerobic conditioning that are fundamental to improving metabolic health, body composition, and endothelial function.

These interventions are not a replacement for medical therapy—they are powerful amplifiers that help every other part of the treatment plan work better.

Clinical Observations from My Practice

In our El Paso clinic, I have consistently observed several patterns:

• Patients with metabolic syndrome and ED show the most dramatic improvements when a multi-pronged approach is used: combining PDE5 inhibitors, nitrate-rich diets, sleep apnea treatment, and a structured exercise program that includes pelvic floor rehab.
• LiSWT results are most promising in men with mild to moderate vasculogenic ED who are simultaneously committed to aggressive lifestyle changes.
• Intracavernosal therapy remains a highly reliable and satisfying second-line option for men with severe vascular compromise, such as long-standing diabetes.
• Involving a partner in the counseling process significantly improves treatment adherence and overall satisfaction for the couple.

Key Takeaways

• Erectile dysfunction is primarily a vascular condition and a powerful predictor of systemic cardiovascular health. Treat the whole patient, not just the symptom.
• A diagnosis of low testosterone requires a rigorous, evidence-based approach. Always address reversible causes, such as obesity and sleep apnea, first.
• A foundational layer of lifestyle optimization—nutrition, exercise, and sleep—is critical for the success of any medical therapy.
• PDE5 inhibitors are a highly effective first-line therapy for many, but advanced options like intracavernosal injections and penile implants offer reliable solutions when needed.
• Low-intensity shockwave therapy is an emerging restorative option that may improve underlying penile microvascular function in select patients.
• If TRT is initiated, it must be done with personalized formulation, clear goals, and meticulous safety monitoring for hematocrit, PSA, and cardiovascular markers.
• Integrative chiropractic care with medical oversight enhances outcomes by improving autonomic balance, biomechanics, circulatory conditioning, and capacity for regular exercise, supporting durable, holistic results.

References

• American College of Sports Medicine. (2021). ACSM’s Guidelines for Exercise Testing and Prescription.
• Araujo, A. B., Esche, G. R., Kupelian, V., O’Donnell, A. B., Travison, T. G., Williams, R. E., Clark, R. V., & McKinlay, J. B. (2007). Prevalence of symptomatic androgen deficiency in men. The Journal of Clinical Endocrinology & Metabolism.
• Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Wu, F. C. (2018). Testosterone therapy in men with hypogonadism: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 103(5), 1715–1744.
• Burnett, A. L., Nehra, A., Breau, R. H., et al. (2018). American Urological Association Guideline on Erectile Dysfunction. American Urological Association.
• Capogrosso, P., et al. (2015). Pelvic floor muscle training for erectile dysfunction. The Journal of Sexual Medicine.
• Carson, C. C., & Kirshenbaum, E. (2011). Patient satisfaction after penile implant surgery. Therapeutic Advances in Urology, 3(3), 127–132.
• Corona, G., Rastrelli, G., & Maggi, M. (2013). Testosterone and metabolic syndrome: A meta-analysis. The Journal of Sexual Medicine.
• Grossmann, M. (2011). Low testosterone in men with type 2 diabetes: Significance and treatment. The Journal of Clinical Endocrinology & Metabolism.
• Haavik, H., & Murphy, B. (2012). Subclinical neck pain and altered sensorimotor integration following manipulation. Journal of Manipulative and Physiological Therapeutics.
• Hatzimouratidis, K., Giuliano, F., Moncada, I., et al. (2021). European Association of Urology Guidelines on Sexual and Reproductive Health. European Association of Urology.
• Hoyos, C. M., Killick, R., Yee, B. J., Grunstein, R. R., & Liu, P. Y. (2012). Effects of CPAP on testosterone in men with obstructive sleep apnea: A systematic review and meta-analysis. The Journal of Clinical Endocrinology & Metabolism.
• Khera, M., et al. (2023). 2023 AUA Update on Testosterone Deficiency. American Urological Association.
• Krzastek, S. C., Sharma, D., Abdullah, N., & Sultan, S. (2019). Clomiphene citrate and enclomiphene in male hypogonadism. Translational Andrology and Urology.
• Layton, J. B., et al. (2014). Trends in testosterone testing and treatment in the US. JAMA Internal Medicine.
• Lu, Z., et al. (2017). Shockwave therapy for erectile dysfunction: Mechanisms and clinical evidence. The Journal of Sexual Medicine, 14(9), 1135–1144.
• Matz, E. L., et al. (2019). Platelet-rich plasma and stem cell therapies for ED: A review of the evidence. Sexual Medicine Reviews, 7(3), 272–281.
• Montorsi, P., Montorsi, F., & Schulman, C. C. (2003). Erectile dysfunction and cardiovascular risk prediction: The “artery size” hypothesis. European Heart Journal, 24(3), 223–230.
• Mulhall, J. P., Trost, L. W., Brannigan, R. E., et al. (2018). Evaluation and management of testosterone deficiency: AUA guideline. The Journal of Urology.
• Mulligan, T., Frick, M. F., Zuraw, Q. C., Stemhagen, A., & McWhirter, C. (2006). Prevalence of hypogonadism in males aged at least 45 years. International Journal of Clinical Practice.
• Pearlman, A., et al. (2017). Erythrocytosis following testosterone therapy. Sexual Medicine Reviews.
• Pereira, A., et al. (2019). Fenugreek and testosterone: Systematic evidence appraisal. Phytotherapy Research.
• Pickar, J. G. (2002). Neurophysiological effects of spinal manipulation. The Spine Journal.
• Rosen, R. C., et al. (1997). Development and validation of the IIEF. International Journal of Impotence Research, 9(6), 477–489.
• Silva, A., et al. (2017). Exercise training and erectile dysfunction: Systematic review and meta-analysis. The Journal of Sexual Medicine, 14(6), 783–792.
• Wong, C., et al. (2017). Micronutrients and male reproductive function. Asian Journal of Andrology.
• Wu, F. C., Tajar, A., Pye, S. R., et al. (2008). Hypothalamic-pituitary-testicular axis disruptions in aging men. The Journal of Clinical Endocrinology & Metabolism.

SEO tags: erectile dysfunction, low testosterone, low T, hypogonadism, TRT, testosterone replacement therapy, nitric oxide, cGMP, PDE5 inhibitors, tadalafil, sildenafil, intracavernosal injection, penile prosthesis, shockwave therapy, functional medicine, integrative chiropractic, autonomic balance, endothelial function, metabolic syndrome, men’s health, internal medicine oversight, El Paso, Dr. Alex Jimenez, Dr. Maria Guadalupe Cardenas, clomiphene citrate, CPAP and testosterone, obstructive sleep apnea, rehabilitation, musculoskeletal health, hematocrit monitoring, PSA monitoring